- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02630550
Validation of the Cheetah NICOM by Comparison to TEE During Open Vascular Surgery - Pilot Study
December 10, 2015 updated by: Louis-Philippe Fortier, Maisonneuve-Rosemont Hospital
The Cheetah NICOM is a non-invasive cardiac output monitor that has been validated in various clinical contexts but not during the occlusion of major arteries, as takes place in vascular surgery.
The present study will evaluate the precision and validity of the measures taken by the device during open vascular surgery procedures.
The measurements will be compared to the those calculated by transesophageal echocardiography at various key points during the surgeries.
The validity of the cardiac output, stroke volume and stroke volume variation measurements will be evaluated, as well as the device's ability to track rapid changes in cardiac output.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eric Peters
- Phone Number: 514-252-3400
Study Contact Backup
- Name: Nadia Godin, RN
- Phone Number: 3193 514-252-3400
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H1T 2M4
- Recruiting
- Maisonneuve-Rosemont Hospital
-
Contact:
- Nadia Godin, RN
- Phone Number: 3193 252-3400
- Email: ngodin.hmr@ssss.gouv.qc.ca
-
Principal Investigator:
- Louis-Philippe Fortier, MSc,MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing either an open aortic aneurysm repair surgery or a femoral endarterectomy under general anesthesia.
Description
Inclusion Criteria:
- Patient undergoing an elective open aortic aneurysm repair surgery or a femoral endarterectomy under general anesthesia.
- ASA 1-3
Exclusion Criteria:
- Refuses general anesthesia
- Contraindication to transesophageal echocardiography
- Allergy to the glue of the Cheetah NICOM probes
- Severe aortic valve regurgitation
- Thoracic aorta anatomy anomaly
- Unipolar pacemaker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Aortic Aneurysm Repair
The impact of large abdominal retractors and an abdominal aortic cross-clamp on the validity of the Cheetah NICOM's measurements will be evaluated in this group.
|
The Cheetah NICOM will be installed on all patients to evaluate the validity of its measurements.
TEE will serve as gold standard measurements for the evaluation of the Cheetah NICOM.
|
Femoral Endarterectomy
The impact of the clamping of a large peripheral arterial vessel on the validity of the Cheetah NICOM's measurements will be evaluated in this group.
|
The Cheetah NICOM will be installed on all patients to evaluate the validity of its measurements.
TEE will serve as gold standard measurements for the evaluation of the Cheetah NICOM.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validity of Stroke Volume (SV) Measurements by the Cheetah NICOM
Time Frame: Per vascular surgery procedure
|
The SV measured by the Cheetah NICOM will be compared to the one measured by transesophageal echocardiography at multiple time points during the surgery.
|
Per vascular surgery procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stroke Volume (SV) with a vascular cross-clamp
Time Frame: Per vascular surgery procedure when a cross-clamp is installed
|
The SV measured by the Cheetah NICOM will be compared to the one measured by transesophageal echocardiography at multiple points once a vascular cross-clamp is installed.
|
Per vascular surgery procedure when a cross-clamp is installed
|
Stroke Volume (SV) trending ability
Time Frame: Per vascular surgery procedure
|
Between each pair of consecutive data points, the change of SV measurements given by the Cheetah NICOM will be compared to those given by transesophageal echocardiography.
|
Per vascular surgery procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Louis-Philippe Fortier, MD, MSc, Maisonneuve-Rosemont Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (ANTICIPATED)
October 1, 2016
Study Registration Dates
First Submitted
December 2, 2015
First Submitted That Met QC Criteria
December 10, 2015
First Posted (ESTIMATE)
December 15, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
December 15, 2015
Last Update Submitted That Met QC Criteria
December 10, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
Clinical Trials on Cheetah NICOM
-
Carmel Medical CenterCompletedAnesthetized Ventilated PatientsIsrael
-
Indiana UniversityCompletedCardiac Output, Low | PediatricUnited States
-
Universitair Ziekenhuis BrusselCompleted
-
Indiana UniversityCheetah Medical Inc.CompletedFluid Overload | Hypovolemia
-
University of MinnesotaRecruitingSepsis | Septic Shock | HypotensionUnited States
-
Johnson & Johnson Surgical Vision, Inc.RecruitingRefractive ErrorSingapore, India
-
Hopital FochCompletedEpidural Analgesia | LaborFrance
-
University of Colorado, DenverCompleted
-
National University Hospital, SingaporeSingapore Clinical Research InstituteCompletedSepsis | Shock, SepticSingapore
-
Johnson & Johnson Surgical Vision, Inc.RecruitingAstigmatism | MyopiaCroatia, India, Italy, Singapore